200,000+ products from a single source!
sales@angenechem.com
99752-82-6 | 1,1,2,2,3,3,4,4,4a,5,5,6,6,7,7,8,8,8a-octadecafluorodecalin; 1-[1,2,2,3,3,4,5,5,6,6-decafluoro-4-(trifluoromethyl)cyclohexyl]-2,2,3,3,4,4,5,5,6,6-decafluoro-piperidine
CAS No: 99752-82-6 Catalog No: AG003X16 MDL No:
Product Description
Catalog Number:
AG003X16
Chemical Name:
1,1,2,2,3,3,4,4,4a,5,5,6,6,7,7,8,8,8a-octadecafluorodecalin; 1-[1,2,2,3,3,4,5,5,6,6-decafluoro-4-(trifluoromethyl)cyclohexyl]-2,2,3,3,4,4,5,5,6,6-decafluoro-piperidine
CAS Number:
99752-82-6
Molecular Formula:
C22F41N
Molecular Weight:
1057.1766
IUPAC Name:
1,1,2,2,3,3,4,4,4a,5,5,6,6,7,7,8,8,8a-octadecafluoronaphthalene;1-[1,2,2,3,3,4,5,5,6,6-decafluoro-4-(trifluoromethyl)cyclohexyl]-2,2,3,3,4,4,5,5,6,6-decafluoropiperidine
InChI:
InChI=1S/C12F23N.C10F18/c13-1(10(29,30)31)2(14,15)5(20,21)9(28,6(22,23)3(1,16)17)36-11(32,33)7(24,25)4(18,19)8(26,27)12(36,34)35;11-1-2(12,5(17,18)9(25,26)7(21,22)3(1,13)14)6(19,20)10(27,28)8(23,24)4(1,15)16
InChI Key:
IYVCXLAGSZWAEQ-UHFFFAOYSA-N
SMILES:
FC12C(F)(C(F)(F)C(C(C2(F)F)(F)F)(F)F)C(F)(F)C(C(C1(F)F)(F)F)(F)F.FC1(N2C(F)(F)C(F)(F)C(C(C2(F)F)(F)F)(F)F)C(F)(F)C(F)(F)C(C(C1(F)F)(F)F)(F)C(F)(F)F
Properties
Complexity:
1450
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
1056.938g/mol
Formal Charge:
0
Heavy Atom Count:
64
Hydrogen Bond Acceptor Count:
42
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
1057.184g/mol
Monoisotopic Mass:
1056.938g/mol
Rotatable Bond Count:
1
Topological Polar Surface Area:
3.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
| Title | Journal |
|---|---|
| [Influence of Perftoran nanoemulsion on blood plasma concentrations of lipophilic drugs]. | Eksperimental'naia i klinicheskaia farmakologiia 20120101 |
| [Influence of perftoran on pharmacokinetics of hydrophilic drugs]. | Eksperimental'naia i klinicheskaia farmakologiia 20110101 |
| [Pharmacological correction of hypoxic and free-radical disorders in patients with acute myocardial infarction complicated by acute heart failure]. | Eksperimental'naia i klinicheskaia farmakologiia 20100501 |
| [Changes of oxidative and antioxidative properties of blood under the action of perftoran in patients with acute sensorineural loss of hearing]. | Vestnik otorinolaringologii 20100101 |
| [Immunomodulatory role of perfluorane in the preoperative preparation of patients with rhegmatogenous retinal detachment]. | Vestnik oftalmologii 20100101 |
| [Use of perftoran in complex treatment of acute pancreatitis]. | Vestnik khirurgii imeni I. I. Grekova 20090101 |
| Clinical results of the application of perftoran for the treatment of odontogenous abcesses and phlegmons in the maxillofacial region. | Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20080401 |
| Impact of oxygenation of bioartificial liver using perfluorocarbon emulsion perftoran on metabolism of human hepatoma C3A cells. | Artificial cells, blood substitutes, and immobilization biotechnology 20080101 |
| [Feasibility study of perftoran for protection of the brain from ischaemia in operations on extracranial arteries]. | Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery 20080101 |
| [Effect of perfluorane on the time course of changes in endogenous intoxication in victims with severe thermal injury]. | Anesteziologiia i reanimatologiia 20070101 |
| Effect of Perftoran on free radical homeostasis during alcohol withdrawal syndrome. | Bulletin of experimental biology and medicine 20070101 |
| Surfactants reduce platelet-bubble and platelet-platelet binding induced by in vitro air embolism. | Anesthesiology 20051201 |
| [New ways to increasing the yield of laccase from Panus tigrinus fungi]. | Prikladnaia biokhimiia i mikrobiologiia 20050101 |
| Surfactant reduction in embolism bubble adhesion and endothelial damage. | Anesthesiology 20040701 |
| [Effects of perfluorane on delayed hypoperfusion after global transient ischemic attack]. | Anesteziologiia i reanimatologiia 20040101 |
| [Perfluorocarbonic compounds application as a new approach in pathogenic treatment of severe forms of viral hepatitis]. | Klinicheskaia meditsina 20030101 |
| [Method of pharmacological treatment of the consequences of hypoxia in critically ill patients with acute poisoning]. | Anesteziologiia i reanimatologiia 20030101 |
| [Effect of perftoran on the oxidant-antioxidant system in patients with severe trauma and blood loss]. | Anesteziologiia i reanimatologiia 20030101 |
| [Effect of perfluoroorganic compounds on growth of streptomycetes and biosynthesis of antibiotic daunorubicin]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20030101 |
| Perftoran as a means modulating the functional activity of liver macrophages. | Bulletin of experimental biology and medicine 20021201 |
| [Study of protective effect of perftoran on a skin flaps]. | Stomatologiia 20020101 |
| [Biophysics at the turn of the new millenium: perfluorocarbon media and gas-transporting blood substitutes]. | Biofizika 20010101 |
| [Effect of perftoran on experimental hepatitis]. | Eksperimental'naia i klinicheskaia farmakologiia 20010101 |
Related Products
© 2019 Angene International Limited. All rights Reserved.